Integrin subunit beta 6 is a potential diagnostic marker for acute kidney injury in patients with diabetic kidney disease: a single cell sequencing data analysis
<i>ITGB6</i> may serve as a biomarker for early AKI diagnosis in patients with DKD and as a target for early intervention therapies.
Authors
- Feng Jiang (ORCID: https://orcid.org/0000-0002-9293-7479)
- Songtao Shou (ORCID: https://orcid.org/0000-0002-9959-3963)
- Lishuang Zhu (ORCID: https://orcid.org/0009-0003-4414-9501)
- Yaguang Fan (ORCID: https://orcid.org/0000-0001-7246-8858)
- Heng Jin (ORCID: https://orcid.org/0000-0001-9264-1187)
- Yan Zhang (ORCID: https://orcid.org/0009-0008-7415-7189)
- Keke Sun (ORCID: https://orcid.org/0009-0009-2534-3265)
- Qihui Liu (ORCID: https://orcid.org/0000-0002-8985-1906)
- Heng Wu (ORCID: https://orcid.org/0000-0002-9022-1290)
- Ziwei Li (ORCID: https://orcid.org/0009-0009-1923-1611)
- Congcong Yao (ORCID: https://orcid.org/0009-0005-4911-7730)
- Hongshuang Su (ORCID: https://orcid.org/0009-0002-0135-9114)
Institutions
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1080/0886022x.2024.2409348
- Citations
- 5
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- National Natural Science Foundation of China
- Tianjin Medical University
- Tianjin Municipal Education Commission
- Tianjin Municipal Science and Technology Bureau